Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
about
Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements inBerberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injuryStretch-activated signaling pathways responsible for early response gene expression in fetal lung epithelial cellsTime course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis.Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injuryPitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMCTranscription factor and kinase-mediated signaling in atherosclerosis and vascular injury.DNAzymes and cardiovascular disease.Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 tPitavastatin suppresses mitogen activated protein kinase-mediated Erg-1 induction in human vascular smooth muscle cells.Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancerEarly growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury.Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice.The role of MAPKs in B cell receptor-induced down-regulation of Egr-1 in immature B lymphoma cells.Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta.An Egr-1-specific DNAzyme regulates Egr-1 and proliferating cell nuclear antigen expression in rat vascular smooth muscle cells.Induction of early growth-response factor 1 by platelet-derived growth factor in human airway smooth muscle.Modulation of cyclin D1 and early growth response factor-1 gene expression in interleukin-1beta-treated rat smooth muscle cells by n-6 and n-3 polyunsaturated fatty acids.Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers.The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.Permeability of injured blood brain barrier for exogenous bFGF and protection mechanism of bFGF in rat brain ischemia.Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.Suppression of growth factor expression and human vascular smooth muscle cell growth by small interfering RNA targeting EGR-1.
P2860
Q28574779-85B9BA20-A76B-4B88-B401-F3E77056D870Q28576577-ECBC5BCE-9C8F-4798-B643-580044B9F525Q28584123-4B5A54B1-819B-44D6-9749-20C9C261BB40Q33831008-B74B5041-A9E5-49AF-902A-EDCB8C87E639Q33925818-A146B368-731F-4D7C-8DC6-8B850E9ED6F8Q34021089-E2B01674-AC60-46E1-9F25-14D603AC519EQ34082126-D4D4FBC9-EE83-4C28-BFFA-0E030737781EQ35788203-2044F86D-46DA-406A-A61F-9EDECFCFC2D9Q36260730-0C0D6075-F8D3-44D4-99DD-5BF6C5D12FFCQ36461109-8349DCA4-1482-4975-9468-3395D8A33896Q37153589-8946A625-C390-488B-8F5A-9EAD688B7BE7Q37158392-3B60C1A3-445C-46F3-AA4B-EBA6171989F6Q37165112-61161C6B-7DFA-46A6-B02C-C2088765ECFFQ37299283-26506E0D-F00F-4969-869D-DF940BE00875Q38303221-0B0D2B92-F6F3-4DF6-99DA-AF9720DDA8E4Q38345332-49D0C962-C18D-4587-A40A-D023E011DF9CQ40215697-2EEDB318-6843-47A7-9C0B-10DF9DFDA14CQ40548571-A64AA825-9901-49E0-98D4-87DDB4840DEAQ40663928-9A6D199C-CC82-4154-B627-0BB57F67AB87Q41482681-D03ED385-80F3-414C-9895-604E29CC9007Q42830989-191A0100-0BF1-4407-93A6-2971A0C97D11Q45160531-2B9343BC-F796-44A2-ACB5-203EA8944A9DQ46949767-7B4FBC49-730F-4715-9950-C18B866F08FCQ47678239-9EC73E26-8A10-46F7-AF9A-6CD28B93F651Q48498326-4972640B-5790-49F2-B781-4B78EE91A439Q54037308-4E8808A5-6163-41CB-A081-B68ACC4CDC25Q54567024-00EDE37F-9E0D-478F-BE00-F7A9347F75C9
P2860
Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Vascular smooth muscle cell pr ...... ro are Egr-1/NGFI-A-dependent.
@ast
Vascular smooth muscle cell pr ...... ro are Egr-1/NGFI-A-dependent.
@en
type
label
Vascular smooth muscle cell pr ...... ro are Egr-1/NGFI-A-dependent.
@ast
Vascular smooth muscle cell pr ...... ro are Egr-1/NGFI-A-dependent.
@en
prefLabel
Vascular smooth muscle cell pr ...... ro are Egr-1/NGFI-A-dependent.
@ast
Vascular smooth muscle cell pr ...... ro are Egr-1/NGFI-A-dependent.
@en
P2860
P1476
Vascular smooth muscle cell pr ...... tro are Egr-1/NGFI-A-dependent
@en
P2093
D G Atkins
F S Santiago
P2860
P304
P356
10.1016/S0002-9440(10)65189-9
P407
P577
1999-09-01T00:00:00Z